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For thousands of women in the United States ovarian cysts, tumors, and hormonal
imbalances contribute to reduced fertility and fecundity. In addition to these factors, many other
unexplained physiological mechanisms may play a role in women’s reproductive health.
Specifically, human follicle stimulating hormone (hFSH) binds to a G protein coupled receptor
(GPCR) called human follicle stimulating hormone receptor (hFSHR). This interaction helps to
regulate the reproductive system in both males and females indicating that it may be a key player
to target in order to promote fertility. Previous work in our lab has demonstrated that hFSHR,
like other GPCR, has been shown to preferentially localize within microdomains in the cell
membrane known as lipid rafts in order to facilitate proper signaling. This localization is thought
to be mediated in part by a protein known as caveolin. In order to investigate the relationship
hFSHR and caveolin, a cell line expressing hFSHR (HEK293-hFSHR) was transfected with a
plasmid to transiently express caveolin. Immunoprecipitations were used to investigate the
interaction between caveolin and full length hFSHR. Western blot analysis was subsequently
performed to detect protein interactions. Based on the data generated from this experiment, the
previously established relationship between FSHR and lipid raft residency was not confirmed
because it was not shown that caveolin co-precipitated with FSHR. These findings may suggest
that previous studies used methods that resulted in artifactual phenomenon. However, it is
equally possible that the conditions, plasmids, or cells used in these experiments contributed to
the inability to replicate the results found previously. Understanding the possible interaction
between hFSHR and caveolin is crucial in the future development of therapeutics that will allow
us to fine tune receptor function for infertility treatments.
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Introduction

According to the Society of Reproductive Surgeons, 6.7 million women in the US face
difficulties conceiving. In 2019, roughly six percent of married American women aged 15 to 44
suffered from infertility, while about 12 percent of all American women in the same age group
suffered from impaired fecundity (1). Impaired fecundity refers to the inability to become
pregnant whereas infertility refers to difficulty becoming or staying pregnant. The male partner is
solely responsible for failure to conceive for about eight percent of couples (1). Current
techniques designed to help couples conceive and carry to term include, but are not limited to
pharmacological intervention, surgery, artificial reproductive technology (ART), and artificial
insemination. Surgical techniques such as ovarian cyst or tumor removal aim to remove potential

physical barriers that otherwise prevent normal menses and sometimes restore distorted hormone
levels. Medications prescribed usually supplement reproductive hormones whose production is
nonexistent. For example, the medication Letrozole works by promoting ovulation by reducing
estrogen production thus correcting issues within the female hormone signaling pathways (2).

However, such interventions are not always effective because there are multiple, not fully
understood, influences. Many unexplored factors potentially contribute to infertility and/or
decrease fecundity for many couples. Developing pharmaceutical interventions to combat
infertility is paramount. A 2010 study suggested that pharmacological intervention offers a far
less expensive solution to promote conception. It found that the annual cost of medication for
women undergoing infertility treatments was $1,182, while the average total cost for a woman to
successfully conceive in 18 months or less using IVF was over $61,000 (3). The key to
unlocking new tools to reduce infertility and promote fecundity is by further studying
reproductive hormones and their functions. One such reproductive hormone is follitropin (FSH).

FSH is a regulatory hormone in the hypothalamic-pituitary-gonadal (HPG) axis, which as
one of its roles, helps to regulate the reproductive system in both males and females. The
hypothalamus, as part of the HPG axis, is the neural control center in the forebrain that regulates
temperature control, hunger, thirst, and circadian rhythms through hormonal secretions. The
pituitary gland, located below the hypothalamus in the midbrain, is composed of many tissues
and is responsible for the production of FSH. When stimulated by gonadotropin-releasing
hormone secreted from the hypothalamus, gonadotropic tissue in the anterior pituitary releases

gonadotropin hormones that include human luteinizing hormone (hLH), and human follicle
stimulating hormone (hFSH).

In women, hFSH and hLH both act on the follicular cells of the ovaries to promote
follicle maturation. Follicles are small sacs within the ovaries that are necessary to support
developing egg cells (4) (Figure 1). Progesterone, whose production is also stimulated by hFSH
and hLH activity, signals for growth of the endometrium in the uterus to prepare for egg
implantation. As follicles mature, they produce inhibin, which acts to decrease hFSH production
in the anterior pituitary. An hLH surge during the menstrual cycle causes a follicle to burst
resulting in the release of an egg during ovulation. Post-ovulation, the corpus luteum produces
progesterone inhibiting hFSH, hLH, and GnRH production (5) (Figure 2). Studies have shown
that women lacking this FSH action are infertile (6).

MM Matzuk, DJ Lamb: Nat cell Biol 4:Suppl S41-9, 2002

Figure 1. Follicular maturation and formation of the corpus luteum.

In males, FSH regulates Sertoli cell proliferation and differentiation in the immature testis
and influences various functions of these cells in adult life, thus indirectly maintaining
spermatogenesis. Unlike in women, a lack of FSH action in males appears to only partially
impair fertility (6).

G., H. R. I., & Hanley, N. A. (2012). Essential endocrinology and diabetes: Richard Ig Holt ; Neil A Hanley (6th ed.). Wiley-Blackwell.

Figure 2. Hormonal regulation of the female reproductive system. Red minus signs indicate
inhibition. Blue plus signs indicate activation.
Specific interactions between hormones and their receptors can elicit a large spectrum of
biochemical responses within the target cells. Without its corresponding receptor, hormones are
unable to perform their physiological function. hFSH binds specifically to an extracellular

domain of G protein-coupled receptors known as human follicle stimulating hormone receptor
(hFSHR) (6) (Figure 3A). hFSHR contains 7-transmembrane domains, an extracellular domain
that receives signals from the cell’s environment, and an intracellular domain that facilitates the
propagation of the extracellular signal to the interior of the cell (6) (Figure 3B). Like most G
protein-coupled receptors, the intracellular domain interacts with a heterotrimeric G protein.
When the extracellular domain of hFSHR binds to hFSH, the intracellular domain catalyzes the
exchange of a guanosine diphosphate (GDP) molecule for a guanosine triphosphate (GTP)
molecule bound to the alpha subunit of the heterotrimeric G protein. Eventually, a subunit of the
G protein will catalyze the hydrolysis of GTP to GDP and Pi. The Pi unit then activates a
signaling cascade intracellularly. The G protein remains in a heterotrimeric state, bound to GDP,
until the G protein-coupled receptor is activated to catalyze the exchange of GDP for GTP again
(7).

Huhtaniemi I. The Parkes lecture. Mutations of gonadotrophin and gonadotrophin receptor genes: what do they teach us about
reproductive physiology? J Reprod Fertil. 2000

Figure 3. Human FSHR with combined caveolin binding motif circled in red.

The specific intracellular signaling pathways activated through hFSH-hFSHR interaction
are complex and not fully understood. It is generally accepted that adenosine triphosphate (ATP)
is activated by adenylyl cyclase. Once activated, ATP is converted to cyclic adenosine
monophosphate (cAMP) which then allows for the phosphorylation of the cAMP response
element binding protein (CREB) to phospho-CREB by protein kinase A (8). hFSHR signaling
also leads to beta-arrestin activation which leads to the activation of the MAPK pathway. This
results in the phosphorylation of p44 to phospho-p44 (8). Because cAMP, phospho-CREB, and
phospho-p44 can be detected in biochemical assays, they are commonly used as intracellular
markers to detect hFSHR signaling.

Previous work in our lab has demonstrated that human FSHR (hFSHR), like other
GPCRs, has been shown to preferentially localize within microdomains in the cell membrane
known as lipid rafts in order to facilitate proper signaling (9) (10) (Figure 4). Lipid rafts are areas
of the cell membrane that demonstrate high rigidity and resistance to detergents. These properties
are due to the presence of higher concentrations of sphingolipids and cholesterol than in the
surrounding membrane (9). The uniquely dense membrane composition of lipid rafts is thought
to facilitate colocalization of signaling components which modulates the signaling ability of cells
(11). For example, researchers found that IgE signaling in basophil cells is more efficient when
coordinated via lipid rafts (11). In places where the protein caveolin is present, the lipid raft can
exist as flask shaped invaginations known as caveolae (12). It has been suggested that caveolin, a
scaffolding protein, plays a critical role in hFSHR transit into and out of lipid rafts. A study

using caveolin knockout mice further supports the idea that caveolin plays a role in regulating
signal transduction. In the study, knockout mice deficient in caveolin-1, -2, and -3 were
generated. Pathologies related to signaling molecules and ion channels were induced in their
cardiovascular, pulmonary, urogenital, skeletal, neural, and endocrine systems, as well as
increased susceptibility to cancer (13).

Wells, M., & Cohen, B. D. (2018). Follicle Stimulating Hormone Receptor Signaling is Regulated by Lipid Raft Residency. The FASEB Journal.

Figure 4. hFSHR motility in lipid rafts to facilitate signaling.

Although the specific function of the caveolin-hFSHR interaction is not well understood,
our preliminary data also suggests that caveolin is physically associated with hFSHR. We
hypothesize that for hFSHR to localize within lipid rafts and caveolae, it must interact with
caveolin through a specific sequence in the protein known as the caveolin binding motif (CBM)
(circled in Figure 3 and shown below in Figure 5). This protein sequence is frequently found in
proteins that interact with caveolin, which may suggest that the hFSHR sequence plays an
important role in the hFSH signaling pathway (14) (Table I). The CBM is known to have four
aromatic residues (φ in the sequence in Figure 5). This sequence of ten amino acids in the CBM

follows a φXφXXXXφXXφ pattern, which are considered to be the functional units of this motif.
In the case of FSHR, all φ’s correspond to a phenylalanine (14).

Table I. List of proteins containing CBM sequence that are thought to interact with caveolin-1.

Dominic PB, Dart C, Daniel JR. Evaluating Caveolin Interactions: Do Proteins Interact with the Caveolin Scaffolding Domain through a
Widespread Aromatic Residue-Rich Motif? PLoS One. 2012 Sep 1,;7(9):e44879.

Similarly, hFSHR has four key phenylalanine residues in the fourth transmembrane
domain (F- circled in Figure 3) that are consistent with the CBM. The aromatic residues in this
motif are colloquially referred to as the A, B, C, and D sites. The residues are located at positions
479, 481, 486, and 489, respectively. When viewed in a three-dimensional model, the B site is
oriented opposite from the A, C, and D sites. This suggests that the B site may play a minor role
in the function of this motif due to its isolation from the other aromatic amino acids (Figure 5).

Caveolin Binding Motif:
Wild Type (WT):

φXφXXXXφXXφ
FAFAAALFPIF

Created by Professor Brian D. Cohen.

Figure 4. Helical wheel diagram depicting the CBM of hFSHR with the location of the four
aromatic residues labeled.

Based on prior data suggesting that hFSHR signaling is regulated by lipid raft residency
and the results suggesting a possible role of caveolin in the regulation, this study aimed to further
validate the role of lipid rafts and caveolin in hFSHR signaling regulation. We specifically
investigated caveolin interaction with full length receptors by performing immunoprecipitations.

In our experiments, we first performed western blot analysis of whole cell extract
experiments. Then, we attempted to co-immunoprecipitate hFSHR and caveolin-1 out of solution
using specific antibodies. Previous experiments done in our lab, provide substantial evidence to

suggest that western blot analysis will definitively show that the hFSHR and caveolin-1 are in
physical interaction with each other.

Methods

HEK293-hFSHR cells expressing hFSHR were grown to confluence in Corning cell
culture flasks using a Dulbecco’s Modified Eagle Medium (DMEM) and the antibiotic G418.
Transfections were performed on cells in 60 mm dishes as described in the transit 293 protocol
(Appendix I).

Whole cell extracts were harvested by washing each dish in 1 mL ice cold PBS. Then, 1
mL ice cold PBS/EDTA was added to each dish and allowed to incubate for 5 minutes. The cells
were collected in microfuge tubes and centrifuged at max speed at 4° C for 20 minutes. Pellets
were resuspended in either 1 mL of CHAPS or Octylglucoside buffer. Recipes for the buffers can
be found in Appendices II and III respectively. The microfuge tubes were vortexed and
centrifuged at max speed at 4° C for 20 minutes. The supernatant was transferred to a new tube.

Cells were harvested for co-immunoprecipitations by first placing the 60 mm dishes on
ice. The dishes were washed with 1 mL of ice cold PBS. Then, 1 mL of ice cold lysis buffer was
added to the dishes and allowed to incubate for 20 minutes. The cells were scraped and collected
in microfuge tubes. The samples were transferred from the microfuge tubes to dounce
homogenizers. The samples were transferred back to the microcentrifuge tubes and were then
centrifuged at max speed at 4° C for 30 minutes. The supernatant was transferred to a new tube.

Alternatively, octylglucoside and CHAPS were sometimes used in place of lysis buffer during
cell harvesting.

The gel electrophoresis was conducted at 100V for approximately two hours using 1X
running buffer. The “Good Mojo” Protocol was followed to develop the western blots after
performing SDS-PAGE gel electrophoresis (Appendix V). Alternatively, another protocol for
developing membranes was used when probing with caveolin-1 specific antibody (Appendix VI).

Results and Discussion
Western blot analysis of whole cell extract was performed on two membranes probed
with biotinylated anti-FSHR antibody and biotinylated anti-myc antibody that bound to
myc-tagged caveolin expressed by cultured cells (Figure 5). The left membrane was probed with
biotinylated anti-FSHR antibody and the right membrane was probed with biotinylated anti-myc
antibody. The left blot shows the presence of FSHR indicated by the blue box. These bands are
consistent with what we would have expected because both lanes two and four were loaded with
samples that supposedly contained FSHR. In the right blot, bands consistent with caveolin-1
were present. Consistent with our prediction, bands were present in the lane that contained the
sample transfected with caveolin-1 and not in the lane loaded with samples transfected with
empty vector. This experiment supports the conclusion that both FSHR and caveolin-1 are
expressed in the cells cultured in the lab. In order to confirm this finding, this experiment was
repeated using non-biotinylated antibodies.

Figure 5. Western blot analysis of whole cell extracts experiments. (Left Membrane) Membrane was probed with biotinylated anti-FSHR
antibody. Lanes are 1. Molecular weight marker, 2. Cav+/Lysis buffer, 4. Cav-/Lysis buffer. (Right Membrane) Membrane was probed with
biotinylated anti-caveolin antibody. Lanes are Lanes are 1. Molecular weight marker, 2. Cav+/Lysis buffer, 4. Cav-/Lysis buffer. Blue box
indicates presence of receptor. Red box depicts caveolin protein.

A western blot analysis of whole cell extracts was performed using non-biotinylated
antibodies to demonstrate the expression of both FSHR and caveolin-1 in cells cultured in the lab
(Figure 6). The top blot was probed with a caveolin-1 specific antibody. The red box represents
the region where bands consistent with caveolin-1 might be present. In lanes two-five, caveolin-1
appeared to be present which is consistent with the expected results. Similar bands did not appear
to be present in lanes six-nine. This indicates that caveolin-1 was not present. This finding is
consistent with the expected results because these lanes contained samples that were transfected
with an empty vector. The bottom blot was probed with an anti-FSHR antibody. Bands consistent
with FSHR were present in all lanes. It is interesting to note that the density of the bands were

not uniform. Although an explanation for this phenomena is not available at this time, it is
possible that the lanes were not loaded with a consistent amount of sample. Thus, some bands
appear darker or lighter than others because of the amount of protein present. Overall, this
experiment confirmed the presence of FSHR and caveolin-1 in the cells cultured in the lab.

Figure 6. Western blot analysis of whole cell extracts experiments. Lanes are 1. Molecular weight marker, 2. Cav+/IgG/CHAPS buffer, 3.
Cav+/CHAPS/mAb105, 4. Cav+/IgG/Octylglucoside buffer. 5. Cav+/mAb105/Octylglucoside buffer, 6. Cav-/IgG/CHAPS buffer, 7.
Cav-/mAb105/CHAPS buffer, 8. Cav-/IgG/Octylglucoside buffer, 9. Cav-/mAb105/Octylglucoside buffer. The top membrane was incubated with
an anti-caveolin antibody. The bottom membrane was incubated with an anti-FSHR antibody.

In order to demonstrate the existence of a physical association between FSHR and
caveolin-1, a western blot analysis of co-immunoprecipitation experiments was performed using
non-biotinylated antibodies (Figure 7.) Samples incubated with IgG should not produce bands
that are consistent with receptor being present. Samples incubated with 105, the antibody that
binds to FSHR, should produce bands that are consistent with receptor being present. All
samples transfected with wild type caveolin and probed with a FSHR specific antibody may or
may not produce bands that are consistent with a caveolin and FSHR co-immunoprecipitation.
All other lanes should not show bands consistent with caveolin-1.

The top blot was probed with anti-caveolin-1 antibodies. Bands, boxed in blue, occurred
in lanes four, five, and seven indicating the presence of light-chain antibodies. In addition, darker
bands, boxed in red, presented in lanes four, five, and seven. These bands are consistent with the
presence of heavy-chain antibody. Caveolin-1 should have been present around 20 kD in lanes
three, five, seven, and eight. However, caveolin-1 was not detected in any of the lanes.

The bottom blot was probed with an anti-FSHR antibody. Bands boxed in red presented
in lanes four, five, and seven. They are indicative of light-chain antibodies. Darker bands boxed
in blue presented in lanes four, five, and seven also. They are indicative of heavy-chain
antibodies. Interestingly, FSHR bands were not present in any lanes on this blot. They should
have been present at a higher molecular weight than the heavy-chain antibodies. Without
detecting the presence of receptor or caveolin-1 in any of the two blots, no conclusion can be
drawn as to whether caveolin-1 physically interacts with FSHR because the two moieties did not
co-immunoprecipitated together.

Figure 7. Western blot analysis of co-immunoprecipitation experiments where lanes are; 1. Molecular weight marker, 2.
CAV-/mAb105/Octylglucoside
buffer,
3.
Cav+/mAb105/Octylglucoside
buffer,
4.
CAV-/IgG/Octylglucoside
buffer,
5.
Cav+/mAb105/Octylglucoside buffer, 6. CAV-/mAb105/Lysis buffer, 7. CAV-/IgG/Octylglucoside buffer, 8. Cav+/mAb105/Octylglucoside buffer
(Sample 1), 9. Cav+/mAb105/Octylglucoside buffer (Sample 2). The top membrane was incubated with an anti-caveolin antibody. The bottom
membrane was incubated with an anti-FSH antibody.

In order to confirm the previous findings, the co-immunoprecipitation experiment was
repeated.

Again,

a

western

blot

analysis

of

the

samples

obtained

from

the

co-immunoprecipitation experiments was performed using non-biotinylated antibodies (Figure 8)
The top blot was probed with a caveolin-1 specific antibody. Bands present in lanes four and five
were boxed in red. Most likely, these bands are indicative of non-dissociated heavy and
light-chain antibodies because they occurred in the IgG lane. These bands probably presented
because

the

sample

was

not

heated

for

long

enough

after

performing

the

co-immunoprecipitation. Dark bands that presented in lanes four, five, eight, and nine were

boxed in blue. These bands are consistent with the presence of heavy-chain antibodies. As in the
previous experiment, bands consistent with caveolin-1 did not present. The bottom blot was
probed with an anti-FSHR specific antibody. By in-large the bottom blot contained the same
bands as the blot probed with caveolin-1 did. Both bands consistent with non-dissociated heavy
and light-chain antibodies, as well as heavy-chain antibodies were present. Bands consistent with
FSHR were not detected. As a result, the previous data were confirmed and no conclusion could
be made about the physical association between FSHR and caveolin-1.

Figure 8. Western blot analysis of co-immunoprecipitation experiments where lanes are; 1. Molecular weight marker, 2.
Cav+/mAb105/Octylglucoside buffer, 3. Cav-/mAb105/Octylglucoside buffer, 4. Cav+/IgG/Octylglucoside buffer, 5. Cav-/IgG/Octylglucoside
buffer, 6. Cav+/mAb105/Lysis buffer, 7. CAV-/mAb105/Octylglucoside buffer, 8. Cav+/IgG/Lysis buffer, 9. Cav-/IgG/Lysis buffer. The top
membrane was incubated with an anti-caveolin antibody. The bottom membrane was incubated with an anti-FSH antibody.

Before future studies are conducted, time should be devoted to finding the specific details
of the successful co-immunoprecipitation procedure used by a previous research student. A
former thesis student in the Cohen Lab was able to successfully show a physical association
between FSHR and caveolin-1. After this procedure is found, a determination can be made as to
whether the results of the respective experiments are an artifact of the protocol used. It is
possible that changing the detergent used to lyse cells, or the stringency of the detergent may
produce results consistent with previously collected data. Furthermore, a caveolin-1 specific
antibody could be utilized to probe from caveolin instead of an antibody that binds to a caveolin
protein with a myc-tag that was transfected in this experiment. Using a caveolin-1 specific
antibody we can look for native as well as transfected caveolin rather than just non-native
caveolin transfected with a myc-tag.

Overall, it was confirmed through western blot analysis of whole cell experiments that
caveolin and hFSHR expressed in HEK293R cells cultured in the lab. FSHR was detected using
anti-FSHR antibody and caveolin was detected using both an anti-caveolin antibody and .
However, pulldown experiments did not produce visible bands consistent with hFSHR or
caveolin. The bands that were detected were consistent with IgG antibodies. Despite prior data, a
physical association between caveolin and hFSHR was not identified at this time.

Understanding the interaction between hFSHR and caveolin can provide a deeper
understanding into hFSHR function and potential dysfunction. Having more knowledge about
normal receptor function could allow for the development of biased agonists or antagonists to

allow us to fine tune receptor function for assisted reproduction technologies or for other
infertility treatments.

Families struggling to conceive are forced to face astronomical expenses or the reality of
a childless life. The associated emotional stress diminishes the quality of life for many (15).
Those patients whose infertility may be caused by FSHR related mechanisms cannot yet be
identified due to an insufficient understanding of signaling pathways.

Another perspective represents the millions of Americans who do not want to have
children. The recent increase in intrauterine device (IUD) popularity demonstrates the growing
need for birth control methods with minimal side effects than current hormonal methods (16). A
deeper understanding of the FSH signaling pathways will allow for innovative family planning
solutions that empower people to better choose when they begin or grow their families.

Appendices

Appendix I

After the cells were grown to confluence, cells were split onto 60 mm dishes. 500 microliters of
serum free medium, 6.75 microliters of caveolin (1778 ng/uL), and 20 microliters of transit 293
were added to a microfuge tube and pipetted up and down gently. The contexts were allowed to
incubate for 15 minutes. 250 microliters were added to each of two 60 mm dishes. Empty vector
caveolin was transfected into the cells as a control.

Appendix II

Recipe for CHAPS:
Cell suspensions were diluted 4-fold in “CHAPS buffer,” containing 50 mM Tris-HCl (pH 7.4),
20 mM CHAPS, 125 mM NaCl, 2 mM dithiothreitol, 0.1 mM EGTA, 4 µM tetrahydrobiopterin,
1 mM L-arginine and protease inhibitors as above

Appendix III

Recipe for Octylglucoside:
Combined 10 mM Tris-Cl, pH 8, 150 mM NaCl, 60 mM octyl glucoside, and 1 protease inhibitor
pellet per 10ml.

Appendix IV

Recipe for 100 mL lysis buffer:
Combine, 1.0 mL Igepal CA-640, 0.4 g Sodium Deoxycholate, 20 mL 50mM Tris HCl, pH 7.4, 1
mL 500mM EDTA, 0.82 g Sodium Chloride or, 2.8 mL 5M Sodium Chloride, and add ddi water
to final volume. Immediately before use aliquot the necessary amount and add protease and
phosphatase inhibitors

Appendix V

After transferring the gel to a membrane using standard western blot techniques, the membrane
was washed in 1x TBST three times in five minute intervals. Then, it was incubated with 20 mLs
of 5% BSA overnight. The membrane was then blocked with unlabeled streptavidin in 5% BSA
(100 microliters streptavidin/ 10ml 5% BSA) for one hour at room temperature. The membrane
was then washed with 1x TBST 3 times, for 5 minutes. The membrane was then blocked with
free biotin in 5% BSA (1 mg biotin/ 10 ml 5% BSA) for one hour at room temperature. The
membrane was then washed with 1x TBST 3 times, for 5 minutes. The membrane was then
probed with a biotinylated antibody in 5% BSA (10 microliters antibody/ 10ml 5% BSA)
overnight at 4° C. The membrane was then washed with 1x TBST 3 times, for 5 minutes. The
membrane was then probed with streptavidin-HRP in 5% BSA (10 microliters streptavidin-HRP/
10ml 5% BSA) overnight at 4° C. The concentrations of all antibodies were 1mg/mL

Appendix VI

After transerfing the SDS-PAGE gel to a membrane, it was washed in 1x TBST three times in
five minute intervals. Then, it was incubated with 20 mLs of 5% milk overnight. The membrane
was then incubated with primary antibody in 5% BSA (2 microliters/ 10ml 5% BSA) overnight
at 4° C. The membrane was then washed with 1x TBST 3 times, for 5 minutes. The membrane
was then incubated with secondary in 5% BSA (2 mg secondary/ 10ml 5% BSA) overnight at 4°
C. After, the membrane was washed a final time with 1x TBST 3 times, for 5 minutes. All
membranes were developed using Lab Imager.

Appendix VII

A confluent 60mm dish of cells provides enough extract for at least 2 IPs. Do all steps on ice or
at 4°C.

Rinse cells with 1X PBS, add 1.0 ml ice-cold octylglucoside buffer or lysis buffer/dish , incubate
on ice for 10 min., harvest cells into microfuge tubes, dounce homogenize with 10 strokes (tight
pestle), spin in microfuge at at 4°C, 13,000rpm for10 min, save supernatant.

Add 5ug Ab (105 or IgG2b), vortex gently, incubate at 4°C overnight (don't need to rock, etc.).

Add 100µL of protein A-agarose beads, incubate at 4°C for 2h with end-over-end rotation.

Underlay extract with 0.5ml cushion of 0.5x octylglucoside/30% sucrose or 0.5 x lysis

buffer/30% sucrose, microfuge for 20 seconds, remove supernatant
wash beads twice more with 0.5ml 0.5x octylglucoside buffer or lysis buffer.

Resuspend beads in 60µL 2x sample buffer, heat for 5 minutes at 75oC, centrifuge for 1 min at
max speed, transfer supernatant to a new tube and store at -20°C.
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